Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries

Movement Disorders : Official Journal of the Movement Disorder Society
Hiroyuki TomiyamaNobutaka Hattori

Abstract

We screened LRRK2 mutations in exon 41 in 904 parkin-negative Parkinson's disease (PD) patients (868 probands) from 18 countries across 5 continents. We found three heterozygous missense (novel I2012T, G2019S, and I2020T) mutations in LRRK2 exon 41. We identified 11 (1.3%) among 868 PD probands, including 2 sporadic cases and 8 (6.2%) of 130 autosomal dominant PD families. The LRRK2 mutations in exon 41 exhibited relatively common and worldwide distribution. Among the three mutations in exon 41, it has been reported that Caucasian patients with G2019S mutation have a single-founder effect. In the present study, Japanese patients with G2019S were unlikely to have a single founder from the Caucasian patients. In contrast, I2020T mutation has a single-founder effect in Japanese patients. Clinically, patients with LRRK2 mutations had typical idiopathic PD. Notably, several patients developed dementia and psychosis, and one with I2020T had low cardiac (123)I-metaiodobenzylguanidine (MIBG) heart/mediastinum ratio, although the ratio was not low in other patients with I2020T or G2019S. Clinical phenotypes including psychosis, dementia, and MIBG ratios are also heterogeneous, similar to neuropathology, in PD associated with LRRK2 mutat...Continue Reading

References

Oct 8, 1998·The New England Journal of Medicine·A E Lang, A M Lozano
Oct 17, 1998·Nature·E LeroyM H Polymeropoulos
May 29, 2000·The New England Journal of Medicine·C B LückingUNKNOWN European Consortium on Genetic Susceptibility in Parkinson's Disease
Mar 14, 2002·Annals of Neurology·Manabu FunayamaFumiya Obata
Jun 19, 2002·Acta Neuropathologica·John E DudaJohn Q Trojanowski
Apr 17, 2004·Science·Enza Maria ValenteNicholas W Wood
Nov 16, 2004·Neuron·Coro Paisán-RuízAndrew B Singleton
Jan 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·H NagayamaY Katayama
Feb 1, 2005·Lancet·William C NicholsUNKNOWN Parkinson Study Group-PROGENI investigators
Feb 1, 2005·Lancet·Alessio Di FonzoUNKNOWN Italian Parkinson Genetics Network
Feb 1, 2005·Lancet·William P GilksNicholas W Wood
Feb 11, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Masahiko SuzukiKiyoharu Inoue
Feb 26, 2005·Annals of Neurology·Dena G HernandezAndrew B Singleton
Apr 27, 2005·Annals of Neurology·Jan O AaslyMatthew Farrer
May 10, 2005·Annals of Neurology·Manabu FunayamaFumiya Obata
Jul 2, 2008·Parkinsonism & Related Disorders·Z K WszolekR F Pfeiffer

❮ Previous
Next ❯

Citations

Dec 17, 2009·Archives of Neurology·Roy N AlcalayKaren S Marder
Sep 17, 2009·Journal of Neural Transmission·Avner ThalerNir Giladi
Oct 1, 2009·Journal of Neural Transmission·Rivka Inzelberg, Simon D Israeli-Korn
Oct 17, 2008·Journal of Human Genetics·Hiroyuki TomiyamaNobutaka Hattori
Jul 11, 2006·Current Neurology and Neuroscience Reports·Kristoffer Haugarvoll, Zbigniew K Wszolek
Mar 4, 2010·Human Molecular Genetics·Suzanne LesageUNKNOWN French Parkinson's Disease Genetics Study Group
Feb 9, 2012·Cold Spring Harbor Perspectives in Medicine·Christine Klein, Ana Westenberger
Sep 15, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H A HanagasiM Emre
Jan 12, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E LohmannM Emre
Apr 13, 2011·Neurology India·Bejoy VijayanAsha Kishore
Jan 12, 2011·Journal of Neurology·Francesc ValldeoriolaEduardo Tolosa
Sep 7, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·D A GrimesD E Bulman
Jun 30, 2014·Neurobiology of Aging·Taku HatanoNobutaka Hattori
Jan 11, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Naomi P VisanjiConnie Marras
Jan 19, 2008·Neuroscience Letters·Márcia Mattos Gonçalves PimentelCíntia Barros Santos-Rebouças
Aug 5, 2008·Neurobiology of Disease·Anthony K F LiouMichael J Zigmond
Apr 30, 2017·Human Molecular Genetics·Marian Blanca RamírezSabine Hilfiker
Nov 14, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Jason P CovyBenoit I Giasson
Nov 4, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Eng-King TanJian-Jun Liu
May 1, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Joaquim J FerreiraVincenzo Bonifati
Jun 29, 2007·Neuro-degenerative Diseases·Suzanne LesageUNKNOWN French Parkinson's Disease Genetics Study Group
Jul 11, 2007·Current Opinion in Neurology·Christine Klein, Katja Lohmann-Hedrich
Nov 3, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Aldo QuattroneFrancesca Condino
Nov 26, 2008·Journal of Neuroscience Research·Payal N GandhiAmy L Wilson-Delfosse
May 28, 2009·Human Mutation·Coro Paisán-Ruiz
Nov 28, 2009·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Caroline PirkeviA Nazli Başak
Feb 4, 2010·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Jean-Marc Taymans, Mark R Cookson
Oct 27, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Manabu FunayamaNobutaka Hattori
Mar 18, 2006·Nature Reviews. Genetics·Matthew James Farrer
Apr 13, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Yue HuangCarolyn M Sue
Feb 23, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Chin-Hsien LinRuey-Meei Wu
Oct 21, 2011·Physiological Reviews·Olga CortiAlexis Brice
Jun 1, 2006·Journal of Clinical Neurology·Chong Sik LeeJae Seung Kim
May 26, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Javier Ruiz-MartínezJosé F Martí Massó
Sep 20, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Maya AndoNobutaka Hattori
Sep 18, 2020·Annals of Clinical and Translational Neurology·Weiwei ZhangLu Shen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.